Wednesday, October 20th, 2021 PRESS RELEASE Cubresa Enters into BrainPET Technology License Agreement with the Sino Canadian Health Institute Winnipeg, MB – October 20th, 2021 – Cubresa Inc., a world leader in the design and development of PET Insert systems for MRI, and the Sino Canadian Health Institute (SCHI), a Canadian based wholly owned subsidiary of…
Monday, September 20, 2021 PRESS RELEASE Cubresa enters into Memorandum of Understanding with the University of California, Davis Winnipeg, MB – September 20th, 2021 – Cubresa Inc., a world leader in the design and development of PET insert systems for MRI, has entered into a Memorandum of Understanding (MOU) with the University of California, Davis. The MOU provides a mechanism to identify and potentially pursue specific technical and application-focused research projects related to Alzheimer’s Disease…
Cubresa is pleased to have its clinical BrainPET insert system and preclinical NuPET Bio scanner, designed for use in infectious disease research, featured on page 34 in the June issue of DOTMed’s HealthCare Business News magazine. DOTMed HealthCare link The BrainPET is an investigational device and NOT AVAILABLE FOR COMMERCIAL SALE.
Cubresa is pleased to be featuring its clinical BrainPET insert systems and its preclinical NuPET and NuPET Bio scanners at the ISMRM 2021 Annual Meeting and Exhibition. The virtual exhibition takes place from May 15th to 20th. We look forward to seeing you there!
Cubresa is proud to partner with Lawson, the first research centre that will install the Cubresa BrainPET system for clinical brain imaging research. For more information, click here.
Research Manitoba features Cubresa’s NuPET Bio scanner in their latest Research Today publication. The new scanner is specifically designed for use in biosafety labs and will be used by scientists focused on SARS-CoV-2 research. Research Today Article
Tuesday, November 2nd, 2020 PRESS RELEASE NuPET Bio BSL3 Imaging System Selected by Innovative Solutions Canada to test in COVID-19 Research Program Winnipeg, MB – Cubresa Inc. is pleased to announce that its NuPET Bio imaging system, the first in the world specifically designed for infectious disease research in BSL3 environments, has received a contract…
Cubresa is pleased to be the recipient of the Research Manitoba COVID-19 Innovation Proof-of-Concept Grant. For more information please go to the Research Manitoba website here. To read the press release from Research Manitoba in PDF format, click here.
Cubresa is pleased to be featured in Dotmed’s Health Care Business News Magazine – June 2020 edition. The article, found on page 56, focuses on innovation in the PET and SPECT markets. Dr. James Schellenberg, Cubresa’s Founder and CEO is pleased to share information highlighting the value of its NuPET preclinical insert for SARS-CoV-2 research…
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
About Us
Leadership
Technology
Careers
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4